ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Adda-Lee Graham-Paquin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: DNA Methylation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, New Frontiers in Research Fund, NSERC.
Abstract (Originalsprache)
ZMYM2 is a transcriptional repressor whose role in development is largely unexplored. We found that Zmym2−/− mice show embryonic lethality by E10.5. Molecular characterization of Zmym2−/− embryos revealed two distinct defects. First, they fail to undergo DNA methylation and silencing of germline gene promoters, resulting in widespread upregulation of germline genes. Second, they fail to methylate and silence the evolutionarily youngest and most active LINE element subclasses in mice. Zmym2−/− embryos show ubiquitous overexpression of LINE-1 protein as well as aberrant expression of transposon-gene fusion transcripts. ZMYM2 homes to sites of PRC1.6 and TRIM28 complex binding, mediating repression of germline genes and transposons respectively. In the absence of ZMYM2, hypermethylation of histone 3 lysine 4 occurs at target sites, creating a chromatin landscape unfavourable for establishment of DNA methylation. ZMYM2−/− human embryonic stem cells also show aberrant upregulation and demethylation of young LINE elements, indicating a conserved role in repression of active transposons. ZMYM2 is thus an important new factor in DNA methylation patterning in early embryonic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
- The Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
- Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
- Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan.
- Canadian Center for Computational Genomics,McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Ishtiaque Hossain, Yojiro Yamanaka, Guillaume Bourque, William A Pastor
Förderung
- CIHR
- New Frontiers in Research Fund
- NSERC
- FRQS
- JST
Zitieren
APA
Graham-Paquin, A. L., Saini, D., Sirois, J., Hossain, I., Katz, M. S., Zhuang, Q. K., Kwon, S. Y., Yamanaka, Y., Bourque, G., Bouchard, M., & Pastor, W. A. (2023). ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad540
Vancouver
Graham-Paquin AL, Saini D, Sirois J, Hossain I, Katz MS, Zhuang QK, et al. ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad540
BibTeX
@article{GrahamPaquin2023,
author = {Graham-Paquin, Adda-Lee and Saini, Deepak and Sirois, Jacinthe and Hossain, Ishtiaque and Katz, Megan S and Zhuang, Qinwei Kim-Wee and Kwon, Sin Young and Yamanaka, Yojiro and Bourque, Guillaume and Bouchard, Maxime and Pastor, William A},
title = {ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad540}
}
EUVIMED